Clinical Trials

BRIGHTLINE-3

Link :
Status : PENDING
Population : Various STS subtypes
Description : MDM2i + CPI in selected sarcomas, TP53 WT
PI : A. Razak
Centers Opened : TBD
Phase : III
IIST/Pharma :